NCT00285727View on ClinicalTrials.gov

Ropinirole Controlled Release (CR) as an Adjunctive Agent in the Treatment of Major Depression

NACompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

January 31, 2006

Study Completion Date

October 31, 2007

Conditions
Depressive Disorder, Major
Interventions
DRUG

Ropinirole CR

Trial Locations (2)

9430

Depression Research Clinic, Psychiatry Department, Stanford School of Medicine, Stanford

94305

Stanford University School of Medicine, Stanford

Sponsors
All Listed Sponsors
collaborator

Duke University

OTHER

collaborator

GlaxoSmithKline

INDUSTRY

lead

Stanford University

OTHER

NCT00285727 - Ropinirole Controlled Release (CR) as an Adjunctive Agent in the Treatment of Major Depression | Biotech Hunter | Biotech Hunter